Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

10.72 -0.19 (-1.74%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

2 Superb Dividend Stocks to Buy Today and Hold Forever ↗

January 24, 2023

These two companies have long runways for growth and decent yields today.

Via The Motley Fool

3 Dividend Stocks That Are Ridiculously Cheap Right Now ↗

January 20, 2023

Their valuations are low and their yields are high.

Via The Motley Fool

Could This New Drug Launch Be a Hit for Viatris? ↗

January 12, 2023

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort.

Via The Motley Fool

Is Now the Time to Buy 3 of the S&P 500's Cheapest Stocks? ↗

January 04, 2023

All of these stocks are trading at less than 7 times their future profits.

Via The Motley Fool

Why These 7 Healthcare Stocks Could Soar in 2023 ↗

January 02, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

Via InvestorPlace

Could This Drug News Give a Lift to Eli Lilly Stock? ↗

January 01, 2023

In November, Eli Lilly received positive news from the U.S. Food and Drug Administration.

Via The Motley Fool

Golden Cross Appears Before Viatris Investors ↗

December 15, 2022

Via Benzinga

What Does Viatris' Debt Look Like? ↗

November 21, 2022

Over the past three months, shares of Viatris' Inc. (NASDAQ:VTRS) moved higher by 8.16%. Before having a look at the importance of debt, let's look at how much debt Viatris' has.

Via Benzinga

Expert Ratings for Viatris ↗

November 10, 2022

Within the last quarter, Viatris (NASDAQ:VTRS) has observed the following analyst ratings:

Via Benzinga

1 Passive Income Stock to Buy While It's Cheap and 1 to Avoid ↗

December 29, 2022

Both businesses are well-suited for producing passive income, but only one has the balance sheet and future prospects to make it work.

Via The Motley Fool

3 High-Yielding Dividend Stocks That Could See Hikes in January ↗

December 29, 2022

These stocks all pay more than 3% in dividends.

Via The Motley Fool

'Sell The Darlings, Own The Dogs': Why It May Soon Be Time To Buy Tesla, Meta And Other Worst-Performing Stocks Of 2022 ↗

December 28, 2022

Via Benzinga

The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year ↗

December 21, 2022

These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season.

Via InvestorPlace

Where Viatris Stands With Analysts ↗

November 10, 2022

Viatris (NASDAQ:VTRS) has observed the following analyst ratings within the last quarter:

Via Benzinga

4 Analysts Have This to Say About Viatris ↗

November 10, 2022

Viatris (NASDAQ:VTRS) has observed the following analyst ratings within the last quarter:

Via Benzinga

2 Mammoth Stocks With Dividends to Buy Before 2022 Ends ↗

December 21, 2022

Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season.

Via The Motley Fool

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗

December 18, 2022

These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.

Via InvestorPlace

Want $3,000 in Dividend Income Next Year? Invest $50,000 in These 2 Stocks ↗

December 07, 2022

These stocks have dividend yields exceeding 4%.

Via The Motley Fool

Better Dividend Stock: AbbVie or Viatris? ↗

November 26, 2022

These pharmaceutical companies are profitable and offer above-average dividends.

Via The Motley Fool

3 Stocks With Dividends of 3% or More to Buy on the Dip ↗

November 14, 2022

Three underpriced healthcare stocks provide an opportunity.

Via The Motley Fool

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights

November 10, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

Analyst Ratings for Viatris ↗

November 10, 2022

Over the past 3 months, 4 analysts have published their opinion on Viatris (NASDAQ:VTRS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Want to Collect a High Dividend Every Month? Buy These 3 Stocks ↗

November 10, 2022

Together, these stocks will ensure you're receiving a dividend each month of the year.

Via The Motley Fool

Ocuphire Pharma Shares Jump After Global Licensing Pact For Nyxol Eye Drops ↗

November 08, 2022

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)

November 08, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday ↗

November 08, 2022

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viatris Inc. - Common Stock (NQ:VTRS)

All News about Viatris Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today